Systematic-review and meta-analytic research supports rTMS as a potentially effective intervention for obsessive-compulsive symptoms, with outcomes influenced by the brain target and stimulation protocol.
Why this finding matters
OCD can remain disruptive even when a person has tried medication or evidence-based psychotherapy. The research suggests that targeted brain stimulation may reduce symptoms for some people, while also showing why treatment target and protocol selection matter.
Research Spotlight
Evidence supports symptom reduction
- Meta-analysis
- Multiple stimulation targets
- Sham-controlled trials
- Protocol differences matter
What the evidence suggests
The literature includes stimulation of the supplementary motor area, dorsolateral prefrontal cortex and medial prefrontal/anterior cingulate networks. Recent synthesis concluded that rTMS can be effective for OCD, particularly when specific targets and protocols are used.
What this could mean for you
For clients with persistent OCD symptoms, rTMS may be considered alongside established care such as exposure and response prevention and medication. A consultation helps determine whether neuromodulation belongs in the broader plan.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Could EXOMIND fit your OCD treatment plan?
We can review symptom patterns, previous care and clinical suitability, then explain whether EXOMIND is a reasonable adjunct—not a replacement for appropriate OCD treatment.
Book a Consultation Explore the related Calgary service
Related Calgary service: EXOMIND rTMS Calgary
Study citation
Figueiredo et al. Effects of repetitive transcranial magnetic stimulation on obsessive-compulsive disorder: systematic review and meta-analysis. PMID: 41172156.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.
